These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 33304473)

  • 1. COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?
    Askenase PW
    J Extracell Vesicles; 2020 Oct; 10(1):e12004. PubMed ID: 33304473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel nano therapeutic using convalescent plasma derived exosomal (CP
    Anand K; Vadivalagan C; Joseph JS; Singh SK; Gulati M; Shahbaaz M; Abdellattif MH; Prasher P; Gupta G; Chellappan DK; Dua K
    Chem Biol Interact; 2021 Aug; 344():109497. PubMed ID: 33991505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19.
    Zani-Ruttenstock E; Antounians L; Khalaj K; Figueira RL; Zani A
    Eur J Pediatr Surg; 2021 Aug; 31(4):326-334. PubMed ID: 34161984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
    Taşlı NP; Gönen ZB; Kırbaş OK; Gökdemir NS; Bozkurt BT; Bayrakcı B; Sağraç D; Taşkan E; Demir S; Ekimci Gürcan N; Bayındır Bilgiç M; Bayrak ÖF; Yetişkin H; Kaplan B; Pavel STI; Dinç G; Serhatlı M; Çakırca G; Eken A; Aslan V; Yay M; Karakukcu M; Unal E; Gül F; Basaran KE; Ozkul Y; Şahin F; Jones OY; Tekin Ş; Özdarendeli A; Cetin M
    Front Immunol; 2022; 13():824378. PubMed ID: 35401544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
    Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.
    Jamshidi E; Babajani A; Soltani P; Niknejad H
    Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells and their derived exosomes to combat Covid-19.
    Yousefi Dehbidi M; Goodarzi N; Azhdari MH; Doroudian M
    Rev Med Virol; 2022 Mar; 32(2):e2281. PubMed ID: 34363275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
    Cheng X; Jiang M; Long L; Meng J
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
    [No Abstract]   [Full Text] [Related]  

  • 10. Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Severe COVID-19.
    Xiong J; Chen L; Zhang L; Bao L; Shi Y
    Cell Transplant; 2021; 30():963689721995455. PubMed ID: 33650894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.
    Abdelgawad M; Bakry NS; Farghali AA; Abdel-Latif A; Lotfy A
    Stem Cell Res Ther; 2021 Aug; 12(1):469. PubMed ID: 34419143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?
    Rnjak D; Ravlić S; Šola AM; Halassy B; Šemnički J; Šuperba M; Hećimović A; Kurolt IC; Kurtović T; Mačak Šafranko Ž; Polančec D; Bendelja K; Mušlin T; Jukić I; Vuk T; Zenić L; Artuković M
    Transfus Clin Biol; 2021 Aug; 28(3):264-270. PubMed ID: 33901641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem Cell Derived-Exosomes as Effective Factors in Reducing Cytokine Storm Symptoms of COVID-19.
    Kheirkhah AH; Shahcheraghi SH; Lotfi M; Lotfi M; Raeisi S; Mirani Z
    Protein Pept Lett; 2021; 28(8):945-952. PubMed ID: 33618635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
    Takamatsu Y; Imai M; Maeda K; Nakajima N; Higashi-Kuwata N; Iwatsuki-Horimoto K; Ito M; Kiso M; Maemura T; Takeda Y; Omata K; Suzuki T; Kawaoka Y; Mitsuya H
    J Virol; 2022 Feb; 96(4):e0155121. PubMed ID: 34818068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Endothelial-Cell Extracellular Vesicles as Potential Biomarkers for the Selection of Plasma in COVID-19 Convalescent Plasma Therapy.
    Amri N; Tessier N; Bégin R; Vachon L; Bégin P; Bazin R; Loubaki L; Martel C
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.
    Hassanzadeh A; Rahman HS; Markov A; Endjun JJ; Zekiy AO; Chartrand MS; Beheshtkhoo N; Kouhbanani MAJ; Marofi F; Nikoo M; Jarahian M
    Stem Cell Res Ther; 2021 May; 12(1):297. PubMed ID: 34020704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review.
    Zaffanello M; Piacentini G; Nosetti L; Franchini M
    Transfus Apher Sci; 2021 Apr; 60(2):103043. PubMed ID: 33388249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells.
    Luther KM; Haar L; McGuinness M; Wang Y; Lynch Iv TL; Phan A; Song Y; Shen Z; Gardner G; Kuffel G; Ren X; Zilliox MJ; Jones WK
    J Mol Cell Cardiol; 2018 Jun; 119():125-137. PubMed ID: 29698635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes, and the potential for exosome-based interventions against COVID-19.
    Rahmani A; Soleymani A; Almukhtar M; Behzad Moghadam K; Vaziri Z; Hosein Tabar Kashi A; Adabi Firoozjah R; Jafari Tadi M; Zolfaghari Dehkharghani M; Valadi H; Moghadamnia AA; Gasser RB; Rostami A
    Rev Med Virol; 2024 Jul; 34(4):e2562. PubMed ID: 38924213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.